Vincerx Pharma, Inc. (VINC)
NASDAQ: VINC · Real-Time Price · USD
0.2756
-0.2674 (-49.24%)
At close: Apr 9, 2025, 4:00 PM
0.2652
-0.0104 (-3.77%)
Pre-market: Apr 10, 2025, 9:01 AM EDT
VINC's stock price has decreased by -99.71% in the past year and price targets may not have had time to catch up.
Vincerx Pharma Analyst Ratings
Total Analysts
1
Consensus Rating
Buy
Price Target
$40.00
Upside
+14,413.79%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Buy Maintains $80 → $40 | Buy | Maintains | $80 → $40 | +14,413.79% | Oct 8, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 9, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 1, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $100 | Buy | Reiterates | $100 | +36,184.47% | Sep 7, 2023 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $80 → $60 | Strong Buy | Maintains | $80 → $60 | +21,670.68% | Nov 17, 2022 |
SVB Leerink | SVB Leerink | Buy Maintains $120 → $100 | Buy | Maintains | $120 → $100 | +36,184.47% | Aug 12, 2022 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $440 → $160 | Buy | Maintains | $440 → $160 | +57,955.15% | Jun 8, 2022 |
B. Riley Securities | B. Riley Securities | Strong Buy Maintains $240 → $120 | Strong Buy | Maintains | $240 → $120 | +43,441.36% | Jun 7, 2022 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $220 → $80 | Strong Buy | Maintains | $220 → $80 | +28,927.58% | Jun 7, 2022 |
SVB Leerink | SVB Leerink | Buy Maintains $380 → $120 | Buy | Maintains | $380 → $120 | +43,441.36% | Jun 7, 2022 |
Chardan Capital | Chardan Capital | Strong Buy Maintains $280 → $220 | Strong Buy | Maintains | $280 → $220 | +79,725.83% | May 13, 2022 |
SVB Leerink | SVB Leerink | Buy Maintains $400 → $380 | Buy | Maintains | $400 → $380 | +137,780.99% | May 13, 2022 |
SVB Leerink | SVB Leerink | Buy Maintains $480 → $400 | Buy | Maintains | $480 → $400 | +145,037.88% | Mar 30, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $500 → $560 | Strong Buy | Maintains | $500 → $560 | +203,093.03% | Mar 30, 2022 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $500 | Strong Buy | Initiates | $500 | +181,322.35% | Jan 14, 2022 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $500 | Buy | Initiates | $500 | +181,322.35% | Dec 23, 2021 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.